Ian Clements - Nov 10, 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Financial Officer
Signature
/s/ Jody Howe, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Nov 10, 2022
Transactions value $
$5,542
Form type
4
Date filed
11/14/2022, 08:46 PM
Previous filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $5.54K +325 +1.09% $17.05 30K Nov 10, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 325 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.